Related Experiment Video
Updated: Jul 16, 2026

07:52
Revised and Neuroimaging-Compatible Versions of the Dual Task Screen
Published on: October 5, 2020
Multi-Adversarial Debiasing in Clinical Artificial Intelligence
Md Rahat Shahriar Zawad1, Irene Y Chen2,3, Peter Washington3
1University of Hawaii at Manoa, USA.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|February 23, 2026
Summary
This study introduces a multi-adversarial debiasing framework to improve fairness in clinical machine learning by optimizing multiple fairness metrics simultaneously. The new method effectively reduces demographic parity and disparate mistreatment while maintaining model performance.
Area of Science:
- Machine Learning
- Clinical Informatics
- Algorithmic Fairness
Background:
- Clinical machine learning models can exhibit biases, impacting equitable healthcare outcomes.
- Current debiasing methods often focus on optimizing a single fairness metric, potentially overlooking other bias types.
Purpose of the Study:
- To introduce and evaluate a novel multi-adversarial debiasing framework for clinical machine learning.
- To jointly optimize multiple fairness definitions, specifically demographic parity (DP) and disparate mistreatment (DM).
Main Methods:
- Developed a multi-adversarial debiasing framework extending adversarial debiasing.
- Employed two adversaries representing DP and DM for joint optimization.
- Evaluated the framework on two clinical datasets (UCI Heart Disease, Parkinson's Disease) and two benchmark datasets (COMPAS, Adult Income).
Main Results:
- The multi-adversarial approach successfully reduced DP by 0.03-0.22 and DM by 0.02-0.12 across datasets.
- F1 scores were maintained within 0-16% of baseline models, indicating minimal performance compromise.
- Effectiveness was highest in datasets with balanced representation across protected attributes.
Conclusions:
- Multi-adversarial debiasing offers a more comprehensive approach to mitigating bias in clinical ML than single-metric optimization.
- The framework demonstrates potential for enhancing fairness in healthcare AI applications.
- Dataset characteristics, particularly label representation across protected attributes, influence the efficacy of adversarial debiasing.
More Related Videos
Related Concept Videos
Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Strategies for Assessing and Addressing Confounding
459
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
459
Halo Effect
552
The halo effect is a cognitive bias in which an individual's overall impression influences judgments about their specific traits. This psychological phenomenon leads people to associate positive characteristics with those they perceive as generally good and negative characteristics with those they view as bad. This effect is particularly influential in social perception, professional evaluations, and decision-making processes.The Psychological Basis of the Halo EffectThe halo effect is rooted...
552

